VANCOUVER, British Columbia, Oct. 22, 2019 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) reports right now that EnWave and Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) (NYSE: ACB) a worldwide leader in the cannabis business, have signed an exclusive, royalty-bearing industrial license agreement with sub-licensing rights (the “Agreement”) to use the Company’s proprietary Radiant Power Vacuum (“REV™”) dehydration technologies for the drying of cannabis in Australia. Aurora will hold an exclusive master license for the drying of cannabis utilizing REV™ in Australia and will operate closely with EnWave to pursue sub-licensing possibilities. If particular minimum commercialization specifications are met, Aurora will get an undisclosed share of royalties derived from any cannabis solution dried with REV™ technologies by sub-licensees in Australia.
Concurrently with the signing of the Agreement, EnWave and Aurora have signed a royalty-bearing sublicense (the “Sublicense”) with Cann Group Restricted (“Cann Group”) (ASX: CAN), Australia’s 1st Healthcare Cannabis Cultivation Licensee. The Sublicense grants Cann Group the ideal to use EnWave’s REVTM technologies to dry cannabis in Australia. Pursuant to the Sublicense, Cann Group has signed an gear obtain agreement to acquire a 10kW REV™ machine to initiate industrial production.
The Sublicense is the 1st sublicense granted by Aurora and EnWave and the fifth royalty-bearing industrial license agreement signed by EnWave to dry cannabis utilizing its proprietary dehydration technologies.
About Cann Group Restricted
Established in 2014, Cann Group is the 1st corporation to be issued with a Cannabis Study Licence and Medicinal Cannabis Licence by the Australian Government’s Workplace of Drug Manage (ODC), and was subsequently issued with a Manufacture Licence by the ODC. These Licences authorize Cann Group to cultivate, create and manufacture medicinal cannabis (in association with a relevant permit) for therapeutic and analysis purposes.
Cann Group’s Board and management have in depth practical experience in the agriculture, agronomic and well being analysis sectors and in establishing and commercializing agricultural technologies.
Cann Group has established R&D and cultivation facilities in Australia and is pursuing a totally-integrated enterprise model with collaboration agreements, sources and capabilities that will allow it to establish a top position in plant genetics, breeding, cultivation, production, manufacturing, and clinical evaluation to facilitate the provide of medicinal cannabis for a variety of ailments and health-related situations.
For far more info on Cann Group Restricted, please check out www.canngrouplimited.com.
EnWave Corporation, a Vancouver-primarily based sophisticated technologies corporation, has created Radiant Power Vacuum (“REV™”) – an revolutionary, proprietary process for the precise dehydration of organic supplies. EnWave has additional created patent-pending procedures for uniformly drying and decontaminating cannabis by means of the use of REV™ technologies, shortening the time from harvest to marketable cannabis solutions.
REV™ technology’s industrial viability has been demonstrated and is increasing swiftly across quite a few market place verticals in the meals, and pharmaceutical sectors which includes legal cannabis. EnWave’s tactic is to sign royalty-bearing industrial licenses with business leaders in a number of verticals for the use of REV™ technologies. The corporation has signed more than twenty royalty-bearing licenses to date, opening up nine distinct market place sectors for commercialization of new and revolutionary solutions. In addition to these licenses, EnWave has formed a Restricted Liability Corporation, NutraDried Meals Corporation, LLC, to create, manufacture, market place and sell all-organic cheese snack solutions in the United States below the Moon Cheese® brand.
EnWave has introduced REV™ as the new dehydration common in the meals and biological material sectors: more quickly and less expensive than freeze drying, with superior finish solution high quality than air drying or spray drying. EnWave at the moment has 3 industrial REV™ platforms:
- nutraREV® which is applied in the meals business to dry meals solutions swiftly and at low-price, when sustaining higher levels of nutrition, taste, texture and colour
- powderREV® which is applied for the bulk dehydration of meals cultures, probiotics and fine biochemicals such as enzymes under the freezing point, and
- quantaREV® which is applied for continuous, higher-volume low-temperature drying.
An further platform, freezeREV®, is becoming created as a new process to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. Far more info about EnWave is accessible at www.enwave.net.
Mr. Brent Charleton, CFA
President and CEO
For additional info:
Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: [email protected]
Dan Henriques, CPA, CA, Chief Monetary Officer at +1 (604) 835-5212
E-mail: [email protected]
Deborah Honig, Corporate Improvement at + 1 (647) 203-8793
E-mail: [email protected]
Secure Harbour for Forward-Hunting Info Statements: This press release may possibly include forward-seeking info primarily based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, which includes statements about the Company’s tactic for development, solution improvement, market place position, anticipated expenditures, and the anticipated synergies following the closing are forward-seeking statements. All third celebration claims referred to in this release are not assured to be precise. All third celebration references to market place info in this release are not assured to be precise as the Corporation did not conduct the original major analysis. These statements are not a assure of future functionality and involve a quantity of dangers, uncertainties and assumptions. Though the Corporation has attempted to determine crucial elements that could result in actual benefits to differ materially, there may possibly be other elements that result in benefits not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be precise, as actual benefits and future events could differ materially from these anticipated in such statements. Accordingly, readers must not spot undue reliance on forward-seeking statements.
Neither the TSX Venture Exchange nor its Regulation Solutions Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts duty for the adequacy or accuracy of this release
A photo accompanying this announcement is accessible at https://www.globenewswire.com/NewsRoom/AttachmentNg/575b0754-97d8-44d9-9191-622edd502a55